How Bristol Myers Squibb Is Accelerating Drug Development With AI - Ep. 264

NVIDIA AI Podcast
09/07/2025 31 min Episodio 264
How Bristol Myers Squibb Is Accelerating Drug Development With AI - Ep. 264

Listen "How Bristol Myers Squibb Is Accelerating Drug Development With AI - Ep. 264"

Descargar episodio Ver en sitio original

Episode Synopsis

Greg Meyers, chief digital and technology officer at Bristol Myers Squibb, explains how AI is transforming pharmaceutical research from hypothesis-driven hunches to data-driven discoveries. Learn how the company is using computational chemistry to engineer breakthrough therapies like a sickle cell treatment heading to human trials, and why they built internal AI tools for 25,000+ employees. Learn more at ai-podcast.nvidia.com.

More episodes of the podcast NVIDIA AI Podcast

Lowering the Cost of Intelligence With NVIDIA's Ian Buck - Ep. 284 29/12/2025
How Anyone Can Build Meaningful AI Without Code - Ep. 283 17/12/2025
AI in 2025: From Agents to Factories - Ep. 282 10/12/2025
How AI Data Platforms Are Shaping the Future of Enterprise Storage - Ep. 281 18/11/2025
Mayor Matt Mahan on How AI Is Changing City Life in San Jose - Ep. 280 12/11/2025
AI for Robotics and Manufacturing | GTC Live Washington, D.C. Chapter 5 11/11/2025
AI for Science | GTC Live Washington, D.C. Chapter 4 11/11/2025
AI Infrastructure Ecosystem | GTC Live Washington, D.C. Chapter 3 11/11/2025
Agentic AI for Every Industry | GTC Live Washington, D.C. Chapter 2 11/11/2025
State of AI Innovation | GTC Live Washington, D.C. Chapter 1 11/11/2025
© 2003-2026 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA